{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T22:04:28Z","timestamp":1787954668267,"version":"build-2784847793"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,25]],"date-time":"2019-01-25T00:00:00Z","timestamp":1548374400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["304483\/2015-0"],"award-info":[{"award-number":["304483\/2015-0"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","award":["PPM00610\/15"],"award-info":[{"award-number":["PPM00610\/15"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasites Vectors"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13071-019-3305-2","type":"journal-article","created":{"date-parts":[[2019,1,25]],"date-time":"2019-01-25T11:02:47Z","timestamp":1548414167000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Mannosyltransferase (GPI-14) overexpression protects promastigote and amastigote forms of Leishmania braziliensis against trivalent antimony"],"prefix":"10.1186","volume":"12","author":[{"given":"Christiana Vargas","family":"Ribeiro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruna Fonte Boa","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas de Souza","family":"Moreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Peruhype-Magalh\u00e3es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8523-2155","authenticated-orcid":false,"given":"Silvane Maria Fonseca","family":"Murta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,25]]},"reference":[{"key":"3305_CR1","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1038\/nrmicro1748","volume":"5","author":"F Chappuis","year":"2007","unstructured":"Chappuis F, Sundar S, Hailu A, Ghalib H, Rijal S, Peeling RW, et al. Visceral leishmaniasis: what are the needs for diagnosis, treatment and control? Nat Rev Microbiol. 2007;5:873\u201382.","journal-title":"Nat Rev Microbiol."},{"key":"3305_CR2","unstructured":"World Health Organization. Leishmaniasis. 2018. http:\/\/www.who.int\/en\/news-room\/fact-sheets\/detail\/leishmaniasis . Accessed 10 Sep 2018."},{"key":"3305_CR3","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1111\/j.1529-8019.2009.01272.x","volume":"22","author":"CV David","year":"2009","unstructured":"David CV, Craft N. Cutaneous and mucocutaneous leishmaniasis. Dermatol Ther. 2009;22:491\u2013502.","journal-title":"Dermatol Ther."},{"key":"3305_CR4","first-page":"189","volume-title":"Secretaria de Vigil\u00e2ncia em Sa\u00fade. Departamento de Vigil\u00e2ncia das Doen\u00e7as Transmiss\u00edveis. Manual de vigil\u00e2ncia da leishmaniose tegumentar","author":"Minist\u00e9rio da Sa\u00fade, Brazil","year":"2017","unstructured":"Minist\u00e9rio da Sa\u00fade, Brazil. Secretaria de Vigil\u00e2ncia em Sa\u00fade. Departamento de Vigil\u00e2ncia das Doen\u00e7as Transmiss\u00edveis. Manual de vigil\u00e2ncia da leishmaniose tegumentar. Bras\u00edlia: Minist\u00e9rio da Sa\u00fade; 2017. p. 189."},{"key":"3305_CR5","doi-asserted-by":"publisher","first-page":"e35671","DOI":"10.1371\/journal.pone.0035671","volume":"7","author":"J Alvar","year":"2012","unstructured":"Alvar J, Velez ID, Bern C, Herrero M, Desjeux P, Cano J, et al. Leishmaniasis worldwide and global estimates of its incidence. PLoS One. 2012;7:e35671.","journal-title":"PLoS One."},{"key":"3305_CR6","doi-asserted-by":"publisher","first-page":"e13","DOI":"10.1038\/cti.2014.4","volume":"3","author":"R Kumar","year":"2014","unstructured":"Kumar R, Engwerda C. Vaccines to prevent leishmaniasis. Clin Transl Immunology. 2014;3:e13.","journal-title":"Clin Transl Immunology."},{"key":"3305_CR7","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1128\/CMR.19.1.111-126.2006","volume":"19","author":"SL Croft","year":"2006","unstructured":"Croft SL, Sundar S, Fairlamb AH. Drug resistance in leishmaniasis. Clin Microbiol Rev. 2006;19:111\u201326.","journal-title":"Clin Microbiol Rev."},{"key":"3305_CR8","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/mmi.12178","volume":"88","author":"A Mukherjee","year":"2013","unstructured":"Mukherjee A, Boisvert S, Monte-Neto RL, Coelho AC, Raymond F, Mukhopadhyay R, et al. Telomeric gene deletion and intrachromosomal amplification in antimony-resistant Leishmania. Mol Microbiol. 2013;88:189\u2013202.","journal-title":"Mol Microbiol."},{"key":"3305_CR9","doi-asserted-by":"crossref","unstructured":"Mohapatra S. Drug resistance in leishmaniasis: newer developments. Trop Parasitol. 2014;4:4\u20139.","DOI":"10.4103\/2229-5070.129142"},{"key":"3305_CR10","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.3390\/molecules14072317","volume":"14","author":"F Fr\u00e9zard","year":"2009","unstructured":"Fr\u00e9zard F, Demicheli C, Ribeiro RR. Pentavalent antimonials: new perspectives for old drugs. Molecules. 2009;14:2317\u201336.","journal-title":"Molecules."},{"key":"3305_CR11","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/0006-2952(87)90689-7","volume":"36","author":"JD Berman","year":"1987","unstructured":"Berman JD, Gallalee JV, Best JM. Sodium stibogluconate (Pentostam) inhibition of glucose catabolism via the glycolytic pathway and fatty acid beta-oxidation in Leishmania mexicana amastigotes. Biochem Pharmacol. 1987;36:197\u2013201.","journal-title":"Biochem Pharmacol."},{"key":"3305_CR12","doi-asserted-by":"publisher","first-page":"649","DOI":"10.2174\/1566524043360069","volume":"4","author":"T Naderer","year":"2004","unstructured":"Naderer T, Vince JE, McConville MJ. Surface determinants of Leishmania parasites and their role in infectivity in the mammalian host. Curr Mol Med. 2004;4:649\u201365.","journal-title":"Curr Mol Med."},{"key":"3305_CR13","doi-asserted-by":"publisher","first-page":"9458","DOI":"10.1073\/pnas.0603539103","volume":"103","author":"MF Sernee","year":"2006","unstructured":"Sernee MF, Ralton JE, Dinev Z, Khairallah GN, O'Hair RA, Williams SJ, et al. Leishmania beta-1,2-mannan is assembled on a mannose-cyclic phosphate primer. Proc Natl Acad Sci USA. 2006;103:9458\u201363.","journal-title":"Proc Natl Acad Sci USA."},{"key":"3305_CR14","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jtbi.2014.02.017","volume":"351","author":"S Shinde","year":"2014","unstructured":"Shinde S, Mol M, Jamdar V, Singh S. Molecular modeling and molecular dynamics simulations of GPI14 in Leishmania major: insight into the catalytic site for active site directed drug design. J Theor Biol. 2014;351:37\u201346.","journal-title":"J Theor Biol."},{"key":"3305_CR15","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s00436-010-1852-8","volume":"107","author":"DB Liarte","year":"2010","unstructured":"Liarte DB, Murta SM. Selection and phenotype characterization of potassium antimony tartrate-resistant populations of four New World Leishmania species. Parasitol Res. 2010;107:205\u201312.","journal-title":"Parasitol Res."},{"key":"3305_CR16","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1186\/s13071-016-1930-6","volume":"9","author":"DS Moreira","year":"2016","unstructured":"Moreira DS, Murta SM. Involvement of nucleoside diphosphate kinase b and elongation factor 2 in Leishmania braziliensis antimony resistance phenotype. Parasit Vectors. 2016;9:641.","journal-title":"Parasit Vectors."},{"key":"3305_CR17","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.ijpddr.2013.08.001","volume":"3","author":"DS Moreira","year":"2013","unstructured":"Moreira DS, Monte Neto RL, Andrade JM, Santi AM, Reis PG, Fr\u00e9zard F, et al. Molecular characterization of the MRPA transporter and antimony uptake in four New World Leishmania spp. susceptible and resistant to antimony. Int J Parasitol Drugs Drug Resist. 2013;3:143\u201353.","journal-title":"Int J Parasitol Drugs Drug Resist."},{"key":"3305_CR18","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/0001-706X(93)90083-N","volume":"55","author":"W Huber","year":"1993","unstructured":"Huber W, Koella JC. A comparison of three methods of estimating EC50 in studies of drug resistance of malaria parasites. Acta Trop. 1993;55:257\u201361.","journal-title":"Acta Trop."},{"key":"3305_CR19","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/S0166-6851(03)00079-3","volume":"128","author":"KA Robinson","year":"2003","unstructured":"Robinson KA, Beverley SM. Improvements in transfection efficiency and tests of RNA interference (RNAi) approaches in the protozoan parasite Leishmania. Mol Biochem Parasitol. 2003;128:217\u201328.","journal-title":"Mol Biochem Parasitol."},{"key":"3305_CR20","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1146\/annurev.mi.46.100192.000433","volume":"46","author":"SJ Turco","year":"1992","unstructured":"Turco SJ, Descoteaux A. The lipophosphoglycan of Leishmania parasites. Annu Rev Microbiol. 1992;46:65\u201394.","journal-title":"Annu Rev Microbiol."},{"key":"3305_CR21","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1093\/glycob\/7.7.873-c","volume":"7","author":"BJ Mengeling","year":"1997","unstructured":"Mengeling BJ, Beverley SM, Turco SJ. Designing glycoconjugate biosynthesis for an insidious intent: phosphoglycan assembly in Leishmania parasites. Glycobiology. 1997;7:873\u201380.","journal-title":"Glycobiology."},{"key":"3305_CR22","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1126\/science.1087499","volume":"301","author":"GF Sp\u00e4th","year":"2003","unstructured":"Sp\u00e4th GF, Lye LF, Segawa H, Sacks DL, Turco SJ, Beverley SM. Persistence without pathology in phosphoglycan-deficient Leishmania major. Science. 2003;301:1241\u20133.","journal-title":"Science."},{"key":"3305_CR23","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1016\/j.bbagen.2011.11.001","volume":"1820","author":"RR Assis","year":"2012","unstructured":"Assis RR, Ibraim IC, Nogueira PM, Soares RP, Turco SJ. Glycoconjugates in New World species of Leishmania: polymorphisms in lipophosphoglycan and glycoinositolphospholipids and interaction with hosts. Biochim Biophys Acta. 2012;1820:1354\u201365.","journal-title":"Biochim Biophys Acta."},{"key":"3305_CR24","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0166-6851(98)00047-4","volume":"94","author":"A Descoteaux","year":"1998","unstructured":"Descoteaux A, Mengeling BJ, Beverley SM, Turco SJ. Leishmania donovani has distinct mannosylphosphoryltransferases for the initiation and elongation phases of lipophosphoglycan repeating unit biosynthesis. Mol Biochem Parasitol. 1998;94:27\u201340.","journal-title":"Mol Biochem Parasitol."},{"key":"3305_CR25","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/0166-6851(90)90047-P","volume":"40","author":"M Elhay","year":"1990","unstructured":"Elhay M, Kelleher M, Bacic A, McConville MJ, Tolson DL, Pearson TW, et al. Lipophosphoglycan expression and virulence in ricin-resistant variants of Leishmania major. Mol Biochem Parasitol. 1990;40:255\u201367.","journal-title":"Mol Biochem Parasitol."},{"key":"3305_CR26","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.4049\/jimmunol.144.7.2745","volume":"144","author":"TB McNeely","year":"1990","unstructured":"McNeely TB, Turco SJ. Requirement of lipophosphoglycan for intracellular survival of Leishmania donovani within human monocytes. J Immunol. 1990;144:2745\u201350.","journal-title":"J Immunol."},{"key":"3305_CR27","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1128\/IAI.63.1.43-50.1995","volume":"63","author":"M Kelleher","year":"1995","unstructured":"Kelleher M, Moody SF, Mirabile P, Osborn AH, Bacic A, Handman E. Lipophosphoglycan blocks attachment of Leishmania major amastigotes to macrophages. Infect Immun. 1995;63:43\u201350.","journal-title":"Infect Immun."},{"key":"3305_CR28","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1093\/emboj\/20.1.250","volume":"20","author":"Y Maeda","year":"2001","unstructured":"Maeda Y, Watanabe R, Harris CL, Hong Y, Ohishi K, Kinoshita K, et al. PIG-M transfers the first mannose to glycosylphosphatidylinositol on the lumenal side of the ER. EMBO J. 2001;20:250\u201361.","journal-title":"EMBO J."},{"key":"3305_CR29","doi-asserted-by":"crossref","unstructured":"Ruhela D, Chatterjee P, Vishwakarma RA. 1-oxabicyclic b-lactams as new inhibitors of elongating MPT - a key enzyme responsible for assembly of cell-surface phosphoglycans of Leishmania parasite. Org Biomol Chem. 2005;3:1043\u20138.","DOI":"10.1039\/B418247B"},{"key":"3305_CR30","doi-asserted-by":"publisher","first-page":"950","DOI":"10.2307\/3279246","volume":"61","author":"K Dawidowicz","year":"1975","unstructured":"Dawidowicz K, Hernandez AG, Infante RB, Convit J. The surface membrane of Leishmania. I. The effects of lectins on different stages of Leishmania braziliensis. J Parasitol. 1975;61:950\u20133.","journal-title":"J Parasitol."},{"key":"3305_CR31","doi-asserted-by":"publisher","first-page":"695382","DOI":"10.1155\/2011\/695382","volume":"2011","author":"F Jeddi","year":"2011","unstructured":"Jeddi F, Piarroux R, Mary C. Antimony resistance in Leishmania, focusing on experimental research. J Trop Med. 2011;2011:695382.","journal-title":"J Trop Med."},{"key":"3305_CR32","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/978-3-540-79885-9_16","volume":"190","author":"H Bhattacharjee","year":"2009","unstructured":"Bhattacharjee H, Rosen BP, Mukhopadhyay R. Aquaglyceroporins and metalloid transport: implications in human diseases. Handb Exp Pharmacol. 2009;190:309\u201325.","journal-title":"Handb Exp Pharmacol."},{"key":"3305_CR33","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1084\/jem.167.3.887","volume":"167","author":"SM Puentes","year":"1988","unstructured":"Puentes SM, Sacks DL, da Silva RP, Joiner KA. Complement binding by two developmental stages of Leishmania major promastigotes varying in expression of a surface lipophosphoglycan. J Exp Med. 1988;167:887\u2013902.","journal-title":"J Exp Med."},{"key":"3305_CR34","doi-asserted-by":"publisher","first-page":"3657","DOI":"10.1093\/emboj\/20.14.3657","volume":"20","author":"A Garami","year":"2001","unstructured":"Garami A, Ilg T. Disruption of mannose activation in Leishmania mexicana: GDP-mannose pyrophosphorylase is required for virulence, but not for viability. EMBO J. 2001;20:3657\u201366.","journal-title":"EMBO J."},{"key":"3305_CR35","doi-asserted-by":"publisher","first-page":"8168","DOI":"10.1128\/MCB.21.23.8168-8183.2001","volume":"21","author":"A Garami","year":"2001","unstructured":"Garami A, Mehlert A, Ilg T. Glycosylation defects and virulence phenotypes of Leishmania mexicana phosphomannomutase and dolicholphosphate-mannose synthase gene deletion mutants. Mol Cell Biol. 2001;21:8168\u201383.","journal-title":"Mol Cell Biol."}],"container-title":["Parasites & Vectors"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-019-3305-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13071-019-3305-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-019-3305-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T05:28:55Z","timestamp":1694582935000},"score":1,"resource":{"primary":{"URL":"https:\/\/parasitesandvectors.biomedcentral.com\/articles\/10.1186\/s13071-019-3305-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,25]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["3305"],"URL":"https:\/\/doi.org\/10.1186\/s13071-019-3305-2","relation":{},"ISSN":["1756-3305"],"issn-type":[{"value":"1756-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,25]]},"assertion":[{"value":"8 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"60"}}